CollPlant Biotechnologies Ltd (CLGN) Operating margin 2018–2025
CollPlant Biotechnologies Ltd (CLGN) operating margin by fiscal year — reported operating income divided by reported revenue.
-484.3%FY2025 · since FY2018: -84.7% → -484.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -484.3% | +2865.4 pp |
| FY2024 | -3349.7% | -3281.2 pp |
| FY2023 | -68.5% | +5649.5 pp |
| FY2022 | -5718.1% | -5718.5 pp |
| FY2021 | 0.4% | +91.6 pp |
| FY2020 | -91.2% | +238.0 pp |
| FY2019 | -329.2% | -244.5 pp |
| FY2018 | -84.7% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More CLGN financial trends
CLGN RevenueCLGN Net incomeCLGN Net marginCLGN Gross profitCLGN Gross marginCLGN Operating incomeCLGN Operating cash flowCLGN Free cash flowCLGN Capital expendituresCLGN Return on equityCLGN Stock buybacksCLGN Dividends paidCLGN Total assetsCLGN Total liabilitiesCLGN Shareholders’ equityCLGN overview →